skip to Main Content
Drug Enforcement Administration Newly Classifies CBD as Schedule V Controlled Substance for Epidiolex  


DENVER, CO.—Sept. 27, 2018 Without regard for clear Congressional intent, the United States Drug Enforcement Administration (DEA) continues to act contrary to the express authorizations provided for in Section 7606 of the Agricultural Act of 2014 (the “Farm Bill”) and the Ninth Circuit Court of Appeals’ order in HIA v. DEA III (April 2018). DEA even admitted in that case and its own directive that cannabinoids themselves are not controlled substances, yet now they assert a contradictory position.

In an order that is anticipated to be formally published tomorrow, September 28, 2018, DEA is issuing an interim final rule which would place Epidiolex in Schedule V of the Controlled Substances Act, after FDA’s approval of Epidiolex in June 2018. However, in re-scheduling Epidiolex, DEA overbroadly references not only Epidiolex but additionally any CBD product “derived from cannabis.”Yet again, DEA fails to distinguish such products derived from lawful hemp as being exempted from DEA’s authority and the CSA.

To be clear, the 2014 Farm Bill provisions authorize the cultivation of industrial hemp, and corresponding budgetary legislation (spending provisions) protects the transport, processing, sale, and use of all parts of that hemp across state lines. To this end, the Ninth Circuit Court of Appeals confirmed that Farm Bill hemp is not to be treated as a controlled substance, as the Farm Bill pre-empts the Controlled Substances Act.

While DEA’s handling of Epidiolex was expected, the agency’s seeming disregard for the law, court orders, and its own admissions as to the lawfulness of hemp continues to occur.

This action further underscores the importance, perhaps now more than ever before, of Congress working through its differences and enacting the 2018 version of the Farm Bill, despite recent news this week that those efforts may be delayed until after the November mid-term elections. We note, however, that while we expect hemp to be fully protected in the 2018 Farm Bill, it is more so a function of when the 2018 version of the Farm Bill will be passed by this Congress.

“Given DEA’s tendency to misinterpret and ignore legislation, judicial decisions and its own directive regarding hemp, our firm will swiftly evaluate all available options and remedies for judicial action as in prior HIA v. DEA cases as well as administrative action through notice-and-comment on this new, misguided DEA action,” said Hoban Law Group Managing Partner Bob Hoban.

About Hoban Law Group: Founded in 2008, Hoban Law Group is the leading international law firm specializing in cannabis, CBD and hemp law and policy. Headquartered in Denver, the firm offers expert legal and business counsel across the United States. Visit

Media Contact:

Gaynell Rogers


[email protected]

This Post Has 2 Comments
  1. This article seems to clearly suggest that CBD from hemp (i.e. cannabis less than 0.3% dry weight delta-9-THC) should be classified and regulated in an entirely different manner than CBD from cannabis, while at the same time acknowledging that hemp is a form of cannabis. So if CBD can come from any variety of cannabis, how does one distinguish between 99.9999% pure CBD and 99.9999% pure CBD? This seems to complicate the debate. Instead, wouldn’t market relevant standards for low-THC resin cultivars of cannabis separate from those for high-THC resin cultivars of cannabis make more sense?

Leave a Reply

Your email address will not be published.

Recent Stories

Marijuana labeling system “not an effective or safe way” to detail what’s inside the products, CU study finds

Researchers analyzed labels on 90,000 cannabis products and found them unreliable in describing chemical compounds consumers inhale Marijuana product labels fail to capture “the chemical reality” of what people smoke, a University of Colorado study has concluded after analyzing 90,000 samples offered for sale in six states. The widely used labeling system purported to predict…

Congress might have inadvertently legalized a form of cannabis under Trump

Although marijuana remains strictly forbidden by federal law, a federal appeals court ruled Thursday that Congress quietly amended the statute in 2018 to legalize cannabis cigarettes and vaping products that have similar intoxicants but are made from hemp. The 2018 Farm Bill, signed by President Donald Trump, included provisions removing most legal restrictions on hemp,…

Marijuana regulation bill fails in Delaware House

A bill establishing a structure for regulating the production and sale of marijuana failed in the State House Thursday. State Rep. Edward Osienski’s (D-Newark) bill would have imposed a 15% tax on marijuana sales and created a limited number of licenses for sale, cultivation and testing. Osienski underscored he also sought to address the disproportionate…

Oklahoma House votes to raise costs of commercial medical marijuana licenses

The Oklahoma House of Representatives moved closer to its goal of comprehensive medical marijuana reform on Thursday with the passage of six additional bills, including a substantial hike in the cost of most commercial licenses. House Bill 2179, by Rep. Scott Fetgatter, R-Okmulgee, would create a tiered commercial grower fee structure based on size and…

More Categories

Back To Top
×Close search